Huron’s Q4 RBR up 11.3% to $432M, raises 2026 guidance to $1.78B–$1.86B
Huron's Q4 2025 revenues before reimbursable expenses rose 11.3% to $432.3 million, adjusted EBITDA increased 19.7% to $68 million and adjusted diluted EPS climbed 14.2% to $2.17. Full-year RBR grew 11.9% to a record $1.66 billion, adjusted EPS rose 21% to $7.83 and 2026 RBR guidance is $1.78–1.86 billion.
1. Fourth Quarter 2025 Results
Revenues before reimbursable expenses rose 11.3% to $432.3 million, driven by healthcare and commercial segments, while net income declined to $30.7 million from $34.0 million due to $2.2 million of contingent consideration remeasurement charges. Adjusted EBITDA jumped 19.7% to $68.0 million and adjusted diluted EPS increased to $2.17.
2. Full Year 2025 Performance
Record full-year revenues before reimbursable expenses grew 11.9% to $1.66 billion, and adjusted EBITDA climbed 18.1% to $237.5 million. GAAP net income was $105.0 million after $7.7 million of non-cash impairment charges, while adjusted diluted EPS rose 21% to $7.83.
3. 2026 Guidance and Share Repurchase Program
Huron provided 2026 RBR guidance of $1.78 billion to $1.86 billion, citing AI-driven service demand. The board boosted its share repurchase authorization from $700 million to $900 million and repurchased $166.2 million of stock in 2025, representing 6.6% of outstanding shares.